This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Intercept Pharmaceuticals, Inc., Other. Active years: 2022.
Company Filing History:

Years Active: 2022
Title: Tetsuya Hayama: Innovator in Pharmaceutical Preparations
Introduction
Tetsuya Hayama is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral preparations. With a total of 2 patents, his work focuses on enhancing the efficacy and stability of pharmaceutical formulations.
Latest Patents
Hayama's latest patents include an innovative oral preparation of obeticholic acid. This invention pertains to a quick-release tablet that contains obeticholic acid or a pharmacologically acceptable salt thereof, along with a water-soluble excipient, a disintegrating agent, and a water-soluble polymer binder. The formulation is designed to have exceptional elutability, ensuring rapid absorption. Another significant patent is for a film-coated tablet that boasts high chemical stability of the active ingredient. This film-coated tablet comprises a tablet core containing obeticholic acid and a coating layer that is substantially free from any plasticizer or contains specific types of plasticizers.
Career Highlights
Throughout his career, Tetsuya Hayama has worked with various companies, including Intercept Pharmaceuticals, Inc. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Hayama has collaborated with several professionals in his field, including Mitsuhiro Matono. These collaborations have contributed to the advancement of his innovative work in pharmaceuticals.
Conclusion
Tetsuya Hayama's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an innovator. His work continues to influence the development of effective oral preparations, showcasing the importance of innovation in healthcare.